Literature DB >> 26153821

Impaired pulmonary function is a risk predictor for sudden cardiac death in men.

Sudhir Kurl1, Sae Young Jae, Jussi Kauhanen, Kimmo Ronkainen, Jari A Laukkanen.   

Abstract

OBJECTIVES: Little is known about the association of reduced pulmonary function and the risk of sudden cardiac death (SCD). Our aim was to examine the relation of forced expiratory volume (FEV1), forced vital capacity (FVC), and the ratio of FEV1 to FVC with SCD in a population-based sample of men.
METHODS: This study was based on 1250 men 42-60 years of age without chronic obstructive pulmonary disease, asthma, and lung cancer. During the 20-year follow-up, 95 SCDs occurred. FEV1, FVC, and ratio of FEV1 to FVC were used as lung function tests.
RESULTS: As a continuous variable, each 10% increase in the percentage predicted FEV1 was associated with 18% (adjusted risk 0.82, 95% CI 0.73-0.93, P < 0.002) reduced risk for SCD. Subjects with most reduced (lowest quintile) FEV1 had a 3.5-fold increased risk for SCD (95% CI 1.42-8.41, P = 0.006), after adjustment for conventional risk factors. Similar results were observed with FVC. The results remained statistically significant among non-smokers and smokers respectively.
CONCLUSION: Our study shows that reduced lung function is a robust predictor of SCD in middle-aged men. Lung function test may be useful in risk stratification for SCD in general population.

Entities:  

Keywords:  Prospective study; pulmonary function; sudden cardiac death

Mesh:

Year:  2015        PMID: 26153821     DOI: 10.3109/07853890.2015.1036111

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  4 in total

1.  Association between pulmonary function and cardiac enzymes in sickle cell disease.

Authors:  Charles Antwi-Boasiako; Michael M Asare; Ibrahim Baba; Alfred Doku; Kevin Adutwum-Ofosu; Charles Hayfron-Benjamin; Chamila P Asare; Robert Aryee; Gifty Boatemaah Dankwah; John Ahenkorah
Journal:  Am J Blood Res       Date:  2021-04-15

2.  Genome-wide assessment of gene-by-smoking interactions in COPD.

Authors:  Boram Park; So-My Koo; Jaehoon An; MoonGyu Lee; Hae Yeon Kang; Dandi Qiao; Michael H Cho; Joohon Sung; Edwin K Silverman; Hyeon-Jong Yang; Sungho Won
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

3.  Evolutionary methods for variable selection in the epidemiological modeling of cardiovascular diseases.

Authors:  Christina Brester; Jussi Kauhanen; Tomi-Pekka Tuomainen; Sari Voutilainen; Mauno Rönkkö; Kimmo Ronkainen; Eugene Semenkin; Mikko Kolehmainen
Journal:  BioData Min       Date:  2018-08-14       Impact factor: 2.522

4.  Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies.

Authors:  Yun-Jiu Cheng; Zhen-Guang Chen; Zhu-Yu Li; Wei-Yi Mei; Wen-Tao Bi; Dong-Ling Luo
Journal:  BMC Med       Date:  2021-07-02       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.